Objectives: Activation of coagulation and fibrinolysis is frequently observed in patients with
cancer, even with absence of thrombosis. Furthermore, plasma coagulation parameters …

Patients with pancreatic carcinoma are at an increased risk of venous thromboembolism
(VTE), which is a major cause of morbidity and mortality in various types of cancer. The aim …

Objective: Pancreatic cancer activates coagulation and increases risk of venous
thromboembolism (VTE). We aimed at characterizing the association of hemostatic …

Purpose Activation of coagulation and fibrinolysis is frequently found among cancer patients.
Such tumors are considered to be associated with a higher risk of invasion, metastases, and …

Among cancers, pancreatic cancer is known to be associated with a higher incidence of
venous thromboembolism (VTE). The aim of the study was to determine the implication of …

Background. To elucidate the disturbed hemostatic balance in patients with pancreatic
cancer, the levels of plasma coagulation inhibition and coagulation activation were …

Activated coagulation and fibrinolytic system in cancer patients is associated with tumor
stroma formation and metastasis in different cancer types. The aim of this study is to explore …

Background The aim was to investigate the outcomes associated with venous
thromboembolism (VTE) among irresectable pancreatic cancer patients. Methods This is a …

Background: Venous thromboembolism (VTE) is associated with cancer. Cancer patient with
thromboembolism have poorer prognosis. This study assessed the risk and mortality in …

Aims: The levels of coagulation system tests have been studied in various cancers. In this
study, our aim is to evaluate the prognostic value of pretreatment plasma coagulation tests in …